↓ Skip to main content

End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings

Overview of attention for article published in Blood Advances, December 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
109 Mendeley